T-cell responses induced by SARS-CoV-2 index-virus nanoparticle protein vaccine to the ancestral and omicron variants 6 months following primary vaccination
Published by
Communications Medicine
Summary
journal-article
Highly motivated and accomplished research fellow with over 5 years of experience in immunology, microbiology, biochemistry, vaccinology, and virology. Specialises in molecular assay development, characterization of immune responses, and early-phase design of vaccines and therapeutics, with expertise in research conceptualisation, data analysis, and regulatory compliance (ISO 13485/14001, GMP, GCP, GCLP). Proven leader with a track record of innovation, public speaking, community engagement, technology transfer, and building collaborations between public and private stakeholders to advance the biotechnology and pharmaceutical industries.
Ph.D. Research Fellow
South Africa
→
Medical Laboratory Scientist
South Africa
→
→
Doctor of Philosophy (Ph.D.) Vaccinology
→
Master of Science (M.Sc.) Medical Virology (Cum Laude)
→
Bachelor of Science (B.Sc.) Honours Microbiology
→
Bachelor of Science (B.Sc.) Microbiology, dual-major with Biochemistry
Published by
Communications Medicine
Summary
journal-article
Published by
Scientific Reports
Summary
journal-article
Summary
preprint
Published by
AIDS
Summary
journal-article
Published by
Onderstepoort Journal of Veterinary Research
Summary
journal-article